Batteries play a significant role in the overall safety, performance, and reliability of many life-saving and life-sustaining medical devices. As more medical devices become computerized, compact, and mobile, the number of battery-powered medical devices will continue to increase. While many different components can potentially impact the safety and effectiveness of medical devices, the battery is one of the most critical components. Unexpected depletion or failure of the battery can cause the device to stop functioning properly, preventing the device from delivering life-sustaining or life-saving therapy. The Association for the Advancement of Medical Instrumentation (AAMI) has identified battery management as one of the top 10 challenges for hospital's biomedical departments.
While the FDA has confidence that medical devices currently being marketed will continue to function appropriately, there are opportunities to further improve their overall performance and safety. The FDA organized a Battery-Powered Medical Devices Workshop on July 30-31, 2013 to create awareness of the potential challenges related to battery-powered medical devices and to collaboratively develop ways of ensuring the continued performance and reliability of these devices. The participants included a broad group of stakeholders that are responsible for the design, testing, manufacturing, integration, regulation, selection, purchase, storage, maintenance, and use of batteries throughout the total product life cycle of battery-powered medical devices. The first day focused on the current and future challenges with batteries and battery-powered medical devices. The second day focused on the opportunities, potential solutions, and next steps. Both days included keynote and introductory presentations in the morning intended to encourage further discussion during the breakout sessions in the afternoon.
- Date, Time and Location
- Webcast Archive
- Federal Register Notice
- Public Comment
- Workshop Details
- Contact Us
This meeting was held July 30 and 31, 2013, beginning at 8:00 a.m. at the following location:
FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, MD, 20993
- Morning session 1: Introductions and Keynotes
- Morning session 2: Challenges
- Webcast session 1: Panel discussion
- Webcast session 2: Panel discussion
- Morning session 1: Keynote address and review of Day 1 webcast
- Morning session 2: Opportunities
- Webcast session 3: Panel discussion
- Afternoon session: Future technologies and brainstorming presentations
Breakout session details for in-person participants:
The in-person participants were divided into 8 groups. The CDRH staff worked with the subject matter experts to facilitate the brainstorming sessions.
Laura Adam, Patrick Axtel, Kristen Bowsher, Carole Carey, Simon Choi, Dulciana Chan, Charles Ho, Alan Hoffman, Geetha Jayan, Ron Kaye, Alisson Kumar, Iacovos Kyprianou, Kim Lewandoski-Walker, Mimi Nguyen, Katie O'Calahan, Anindita Saha, Hilda Scharen, Pamela Scott, Jennifer Shih, Ken Skodacek, Pavel Takmakov, Victoria Wagman, Cisco Vicenti
Subject matter experts:
Salil Balar (Aramark), David Bradley (Nationwide Childrens), Chaochao Chen (UMD), Ron Charnock (Kwikpoint), Alex Fay (Quallion), Dominic Frustaci (Greatbatch), John Dumas (Hospira), CDR Mike Krumlauf USPHS (NIH), Chris Lavanchy (ECRI), Alan Lipschultz (AAMI), Mohan Misra (ITN), Joe Padilla (Interstate batteries), Michael Root (Boston Scientific), Tom Skowera (UL), William Sovitsky (USAMMA, PMMD), Like Xie (Palladium)
Breakout session details for webcast participants:
During the in-person breakout sessions there was a panel discussion for the benefit of the webcast participants. On each day 5 panelists discussed challenges and opportunities and the webcast participants provided feedback or ask questions to the panel.
Host/Facilitator: Janesia Simmons (CDRH)
Webcast Support staff: Dharmesh Patel (CDRH), Sophie Wang (CDRH), Geri Smith (CDRH), Carol Krueger (CDRH), Amar Laheri (CDRH)
Panelists Day 1: Bruce Adams (Cadex), Kristen Bowsher (CDRH), Rich Constantineu (Anne Arrundel Health), Antoinette Hazlett (CDRH), Craig Schmidt (Medtronic)
Panelists Day 2: Shah Ashish (Greatbatch), Rich Byczek (INTERTEK), Hamed Ghods (CDRH), William McFarland (CDRH), Bhanu Sood (UMD)
Registration is closed as of July 19, 2013.
There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. Early registration is recommended because seating is limited.
In order to permit the widest possible opportunity to obtain public comment, FDA is soliciting either electronic or written comments on all aspects of the public workshop topics. The deadline for submitting comments is by 5 p.m. on August 30, 2013. Regardless of attendance at the meeting, interested persons may submit their comments regarding this workshop at http://www.regulations.gov/#!documentDetail; D=FDA-2013-N-0580-0001 or to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm.1061, Rockville, MD 20852.
- Food and Beverages will be available for purchase during the breaks.
- Speakers’ and Panelists’ Biographies
If you require special accommodations due to a disability, or need additional information regarding registration, please contact Susan Monahan, Office of Communications and Education Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 66, Silver Spring, MD 20993, 301-796-5661, FAX: 301-847-8142, email@example.com.
For questions regarding workshop content, please contact Dr. Iacovos (Jake) Kyprianou, Center Science Council, Office of Center Director, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 3609, Silver Spring, MD 20993-0002, 301-796-2601, CDRHbatteries@fda.hhs.gov.